Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 12, 2014 (12 years ago)

Captomer

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 74002 5

Recalling firm
Thorne Research Inc
Origin
ID, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1383-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Thorne Research Inc

All 2014 recalls
Class II · Moderate risk

Captomer-250

Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

Terminated Unapproved drug Thorne Research Inc D-1384-2014

Other unapproved drug recalls from 2014

All unapproved drug recalls
Class II · Moderate risk

B-Lipo

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Terminated Unapproved drug Bethel Nutritional Consulting, Inc D-0424-2015
Class I · High risk

Professional Formexx Black

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0990-2015
Class I · High risk

Swoll-250 Super Mass Builder Quad Stack

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0989-2015
Class I · High risk

Estrastain Pro-Anabolic Mass and Hardening Complex

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0988-2015